BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27603426)

  • 21. Long-term survival after radical surgery for renal cell carcinoma with tumour thrombus extension into the right atrium.
    Dominik J; Moravek P; Zacek P; Vojacek J; Brtko M; Podhola M; Pacovsky J; Harrer J
    BJU Int; 2013 Mar; 111(3 Pt B):E59-64. PubMed ID: 22984824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
    Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
    J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis.
    Tsuji Y; Goto A; Hara I; Ataka K; Yamashita C; Okita Y; Kamidono S
    J Vasc Surg; 2001 Apr; 33(4):789-96. PubMed ID: 11296333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
    Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
    BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus.
    Blute ML; Leibovich BC; Lohse CM; Cheville JC; Zincke H
    BJU Int; 2004 Jul; 94(1):33-41. PubMed ID: 15217427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
    Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of renal cell carcinoma with subdiaphragmatic macroscopic venous invasion (T3b).
    Klaver S; Joniau S; Suy R; Oyen R; Van Poppel H
    BJU Int; 2008 Feb; 101(4):444-9. PubMed ID: 18021278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bland thrombus association with tumour thrombus in renal cell carcinoma: analysis of surgical significance and role of inferior vena caval interruption.
    Ayyathurai R; Garcia-Roig M; Gorin MA; González J; Manoharan M; Kava BR; Soloway MS; Ciancio G
    BJU Int; 2012 Dec; 110(11 Pt B):E449-55. PubMed ID: 22540981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
    Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
    Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of radical surgery for renal cell carcinoma with extension into the vena cava.
    Staehler G; Brkovic D
    J Urol; 2000 Jun; 163(6):1671-5. PubMed ID: 10799157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and histological prognostic factors of renal cancer with caval thrombus].
    Bensalah K; Guillé F; Vincendeau S; Rioux-Leclercq N; Manunta A; Lobel B; Patard JJ
    Prog Urol; 2004 Apr; 14(2):160-6; discussion 165. PubMed ID: 15217128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and surgical management of renal cell carcinoma with inferior vena cava tumor thrombus--a report of 6 cases with literature review].
    Li XD; Cheng S; Rui XF; Li GH; Chen YB; Yu DM
    Ai Zheng; 2005 Nov; 24(11):1394-7. PubMed ID: 16552970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inferior vena cava involvement in renal cell carcinoma: comparison of survival rates between patients with thrombus and infiltration.
    Zugor V; Labanaris AP; Lausen B; Schott GE
    Scand J Urol Nephrol; 2008; 42(1):35-9. PubMed ID: 18210335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
    Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
    BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoluminal occlusion of the inferior vena cava in renal cell carcinoma with retro- or suprahepatic caval thrombus.
    Zini L; Haulon S; Leroy X; Christophe D; Koussa M; Biserte J; Villers A
    BJU Int; 2006 Jun; 97(6):1216-20. PubMed ID: 16686714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cava.
    Terakawa T; Miyake H; Takenaka A; Hara I; Fujisawa M
    Int J Urol; 2007 Sep; 14(9):781-4. PubMed ID: 17760741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
    J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.